A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects | MicrobiomeTrials← Back to trialsNCT07301333
A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2025-12-30Est. Completion: 2026-06-16
Enrollment target: 80 participants Locations- Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Other microbiome trials you might be interested in
Fracture Open Tibia
Local application of antibiotics directly to the traumatic wound is a promising treatment for the prevention of infectio…
Dar es Salaam, TanzaniaEst. completion Apr 2028
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Recruiting
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple LocationsEst. completion Mar 2028